Zhongtang Wang Selected Research

Zhongtang Wang Research Topics

Disease

11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 11/2010
9	Neoplasms (Cancer) 04/2022 - 04/2008
4	Radiation Pneumonitis 01/2021 - 09/2011
4	Esophageal Squamous Cell Carcinoma 01/2016 - 11/2009
2	Esophageal Neoplasms (Esophageal Cancer) 02/2022 - 06/2021
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2015 - 12/2014
2	Carcinoma (Carcinomatosis) 11/2009 - 04/2008
1	Esophageal Fistula 02/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Intervertebral Disc Degeneration 10/2020
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Brain Neoplasms (Brain Tumor) 01/2016
1	Hemorrhage 11/2014
1	Arteriovenous Malformations (Arteriovenous Malformation) 11/2014
1	Lung Neoplasms (Lung Cancer) 11/2010
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2008
1	Burns 09/2006

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 10/2020 - 04/2008
2	Biological ProductsIBA 10/2020 - 12/2012
2	monomethoxypolyethylene glycol (MPEG)IBA 01/2017 - 01/2016
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2017 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 02/2016 - 05/2013
2	Peptides (Polypeptides)IBA 01/2016 - 04/2008
1	sintilimabIBA 04/2022
1	Docetaxel (Taxotere)FDA Link 04/2022
1	Immune Checkpoint InhibitorsIBA 04/2022
1	LigandsIBA 01/2017
1	poly(lactide) (polylactic acid)IBA 01/2017
1	IntegrinsIBA 01/2017
1	dilactideIBA 01/2017
1	cyclo(arginyl- glycyl- aspartyl- phenylalanyl- cysteinyl)IBA 01/2017
1	MicellesIBA 01/2017
1	Vinorelbine (Navelbine)FDA LinkGeneric 02/2016
1	Excipients (Suspending Agents)IBA 01/2016
1	Stimuli Responsive PolymersIBA 01/2016
1	Cystine (L-Cystine)IBA 01/2016
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2016
1	polyethylene glycol polyethyleneimine nanogelIBA 01/2016
1	Temozolomide (Temodar)FDA LinkGeneric 01/2016
1	S-1 plus cisplatinIBA 01/2016
1	Superoxide DismutaseIBA 08/2012
1	Tumor Biomarkers (Tumor Markers)IBA 08/2011
1	Carcinoembryonic AntigenIBA 08/2011
1	EnzymesIBA 08/2011
1	Keratin-19 (Keratin 19)IBA 08/2011
1	Phosphopyruvate Hydratase (Enolase)IBA 08/2011
1	ImmunosorbentsIBA 08/2011
1	AntigensIBA 08/2011
1	Therapeutic UsesIBA 11/2010
1	Biological FactorsIBA 08/2010
1	Biomarkers (Surrogate Marker)IBA 11/2009
1	Adenylate KinaseIBA 04/2008
1	Eukaryotic Translation Initiation Factor 5AIBA 04/2008
1	Coloring Agents (Dyes)IBA 04/2008
1	SilverIBA 04/2008
1	Annexin A5IBA 04/2008
1	ProteomeIBA 04/2008
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 04/2008
1	IsoenzymesIBA 04/2008
1	Peptide Elongation Factors (Elongation Factor)IBA 04/2008
1	N 30IBA 09/2006
1	salicylhydroxamic acid (SHAM)IBA 09/2006
1	EndotoxinsIBA 09/2006

Therapy/Procedure

11	Radiotherapy 02/2022 - 09/2011
10	Chemoradiotherapy 10/2021 - 11/2009
5	Drug Therapy (Chemotherapy) 02/2022 - 05/2013
2	Therapeutics 10/2020 - 11/2010
1	Neoadjuvant Therapy 06/2021
1	Segmental Mastectomy (Lumpectomy) 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2016
1	Ligation 11/2014
1	Sutures (Suture) 11/2014
1	Lasers (Laser) 04/2008